WallStSmart
ARWR

Arrowhead Pharmaceuticals Inc

NASDAQ: ARWR · HEALTHCARE · BIOTECHNOLOGY

$73.48
+4.18% today

Updated 2026-04-30

Market cap
$9.88B
P/E ratio
44.08
P/S ratio
9.05x
EPS (TTM)
$1.60
Dividend yield
52W range
$12 – $77
Volume
2.2M

Arrowhead Pharmaceuticals Inc (ARWR) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Total assets$34.53M$29.85M$17.26M$7.70M$12.35M$15.89M$16.53M$37.33M$182.82M$132.27M$128.18M$104.02M$111.61M$349.85M$522.50M$710.15M$691.94M$765.55M$1.14B$1.45B
Cash & equivalents
Current assets$28.78M$25.31M$10.56M$2.48M$8.13M$9.86M$6.57M$28.84M$154.80M$102.87M$90.50M$67.90M$78.77M$265.25M$322.37M$384.60M$405.30M$419.52M$695.47M$950.64M
Total liabilities$2.92M$3.40M$4.95M$2.84M$4.28M$3.32M$7.72M$11.59M$16.83M$22.65M$33.15M$23.16M$16.37M$105.81M$60.72M$301.33M$273.60M$478.39M$948.74M$947.02M
Current liabilities$2.92M$2.90M$3.73M$2.34M$4.28M$2.58M$5.33M$8.73M$11.85M$15.90M$25.64M$18.70M$12.36M$97.07M$40.68M$146.54M$138.85M$105.46M$103.17M$195.49M
Long-term debt$726000.00$500000.00$606786.00$839421.00$1.11M$758000.00$541000.00$2.53M$2.33M$2.10M$393.18M$214.88M
Shareholder equity
Retained earnings$-28.48M$-58.41M$-85.50M$-104.97M$-110.74M$-113.87M$-135.00M$-166.14M$-224.77M$-316.71M$-398.44M$-432.82M$-487.27M$-419.29M$-503.84M$-644.69M$-820.75M$-1.03B$-1.63B$-1.63B
Accounts receivable$74214.00$276064.00$86599.00$147257.00$930683.00$1.61M$2.47M$83663.00$75000.00$75000.00$75000.00$67797.00$327375.00$661361.00$845673.00$10.26M$1.41M$0.00$0.00$6.82M
Inventory$239097.00$0.00$0.00$0.00$0.00$0.00$1.29M$867363.00$1.27M$3.32M$4.25M$4.36M$-21.61M
Goodwill$963150.00$2.94M$2.75M$2.36M$2.05M$1.73M$4.78M$3.24M$1.01M$24.82M$22.16M$20.46M$18.76M$17.06M$15.36M